メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
並べ替え順
Keyphrases
Systemic Inflammation
100%
Head-and-neck Cancer
100%
Cancer Patients
100%
Prognostic Impact
100%
Sarcopenia
100%
Immune Checkpoint Inhibitors
100%
Overall Survival
42%
Inflammatory Markers
42%
Neutrophil-to-lymphocyte Ratio
42%
Platelet-to-lymphocyte Ratio
42%
Progression-free Survival
28%
Prognostic Value
28%
Immune Checkpoint Therapy
28%
Lymphocyte-to-monocyte Ratio
28%
Composite Index
28%
Recurrent or Metastatic
28%
Blood Samples
14%
Significant Predictors
14%
Median Overall Survival
14%
Prognostic Significance
14%
Prognostic Factors
14%
Univariate Analysis
14%
Effective Tool
14%
Survival Outcomes
14%
Chemoradiotherapy
14%
CT Images
14%
Multivariate Cox Analysis
14%
Prognosis Prediction
14%
Independent Prognostic Factor
14%
Poor Survival
14%
Treatment Verification
14%
Adjusted Model
14%
Treatment Response
14%
Cox Regression Analysis
14%
Retrospective Cohort
14%
Kaplan-Meier
14%
Computational Imaging
14%
Skeletal muscle Mass
14%
Treatment Survival
14%
Skeletal muscle Loss
14%
Patient Risk Stratification
14%
L3 Skeletal muscle Index
14%
Cervical CT
14%
Systemic Inflammatory Markers
14%
Medicine and Dentistry
Head and Neck Cancer
100%
Inflammation
100%
Sarcopenia
100%
Immune Checkpoint Inhibitor
100%
Lymphocyte
100%
Overall Survival
50%
Platelet
37%
Skeletal Muscle
37%
Neutrophil
37%
Progression Free Survival
25%
Proportional Hazards Model
25%
Prognostic Factor
25%
Monocyte
25%
Cancer
12%
Univariate Analysis
12%
Body Mass Index
12%
Risk Stratification
12%
Chemoradiotherapy
12%
Treatment Response
12%
Regression Analysis
12%
Immunology and Microbiology
Systemic Inflammation
100%
Neck
100%
Lymphocyte
100%
Immune Checkpoint Inhibitor
100%
Overall Survival
50%
Skeletal Muscle
37%
Platelet
37%
Neutrophil
37%
Monocyte
25%
Progression Free Survival
25%
Pretreatment
25%